[Skip to Content]
[Skip to Content Landing]
Citations 0
July 5, 2006

Medical Management of Peripheral Arterial Disease

Author Affiliations

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2006;296(1):41-42. doi:10.1001/jama.296.1.41-a

To the Editor: In their Clinical Review, Dr Hankey and colleagues1 discussed medical management for peripheral arterial disease (PAD), which they document as a strong risk factor for cardiovascular morbidity and mortality. While I agree with their advice that all patients with this condition warrant treatment with an antiplatelet drug, I disagree with their statement that aspirin is “the preferred antiplatelet drug because it is effective and inexpensive.”

First Page Preview View Large
First page PDF preview
First page PDF preview